Best evidence summary of non-pharmacological management of osteoporosis in patients with androgen deprivation therapy for prostate cancer
10.3760/cma.j.cn115682-20220113-00214
- VernacularTitle:前列腺癌雄激素剥夺治疗患者骨质疏松非药物管理的最佳证据总结
- Author:
Miao GONG
1
;
Haiyan SHAO
;
Yaofen TU
;
Zhenzhu CHEN
Author Information
1. 浙江省人民医院泌尿外科，杭州 310000
- Keywords:
Prostatic neoplasms;
Androgen deprivation therapy;
Osteoporosis;
Evidence-based nursing
- From:
Chinese Journal of Modern Nursing
2022;28(34):4732-4738
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To summarize the evidence of non-pharmacological management of osteoporosis in prostate cancer patients receiving androgen deprivation therapy (ADT) .Methods:The Chinese and English literature databases were searched by computer to select the literature on the non-pharmacological management of osteoporosis in prostate cancer patients with ADT. The retrieval time limit was from the establishment of the database to January 10, 2022. The included articles were summarized after quality evaluation.Results:A total of 9 articles were included, involving 3 expert consensus, 4 systematic reviews, 1 best clinical practice and 1 randomized controlled trial. A total of 35 pieces of evidence were extracted and summarized into 6 categories including risk assessment, nutrition support, exercise, health education, follow-up and monitoring, and remote intervention.Conclusions:This study can provide evidence basis for clinical practice of non-pharmacological management of osteoporosis in prostate cancer patients with ADT. However, the evidence transformation should be flexibly applied in combination with the medical background of our country and the individual conditions of patients.
